Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Amifostine manufacturers

5 products found

Filters

5 products found

amifostine

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783
This pharmaceutical company specializes in the development and production of a wide range of generic and branded medications. Their manufacturing facility, located in an excise-free zone, is WHO-GMP certified and adheres to MHRA UK and TGA standards. They offer various dosage forms, including tablets, capsules, oral liquids, dry syrups, parenterals, MDIs, powders, and ointments. The company focuses on several key therapy areas such as antibiotics, anti-inflammatories, cardiovascular medications, anti-diabetic drugs, oncology products, and vitamins. They export their products to regions including Central Asia and the Caucasus.

Manufacturer usually replies in 2 days

amifostine

Injection 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

amifostine

Injection 500 mg

Dossier type
CTD
Dossier status
Outdated
Country of origin
India
GMP approvals
WHO
Manufacturer #31073
This pharmaceutical company specializes in oncology and has nearly two decades of experience developing generic and specialty drugs. They focus on delivering affordable, world-class chemotherapy medications across a wide range of therapeutic areas. Their robust research and development team possesses expertise in complex drug molecule development, serving diverse markets globally. With over 35 developed generics and specialty drugs, they have filed over 40 dossiers across 25 countries in emerging markets. The company is committed to expanding its presence in the oncology therapeutic area within emerging markets.

Manufacturer usually replies in 6 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation